Illumina

Territory Account Manager 2 - Sao Paulo (Remote)

Sao Paulo, Sao Paulo, Brazil

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates must possess English fluency, a Bachelor's degree in a related field, and at least 3 years of experience in life science capital sales. Knowledge of next-generation sequencing and genotyping is required, along with a strong understanding of clinical and research applied genetics and genomics.

Responsibilities

The Territory Account Manager will develop and execute a territory and account-specific sales plan, utilizing CRM database, delivering technical seminars, demonstrating Illumina product capabilities, partnering cross-functionally, engaging customers in complex sales processes, forecasting sales, managing the sales pipeline, prospecting for new leads, and expanding the customer base. They will also manage existing customer relationships and travel up to 50% of the time, based out of Sao Paulo state.

Skills

Next Generation Sequencing
Genotyping
Life Science Capital Sales
Strategic Selling
Lead Generation
Prospecting
CRM Management
Technical Presentations
Customer Consultation
Complex Sales
Multi-Tiered Sales Process

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI